Contraception

Studies show permanent birth control procedure is option when tubal ligation unsuitable

Published in Medical Device Law Weekly, December 24th, 2006

Conceptus, Inc. (CPTS), developer of the Essure procedure, the first U.S. Food and Drug Administration (FDA)-approved, non-incisional permanent birth control method available, announced that new independent study data show the Essure system eliminates risks associated with traditional surgical sterilization for many women not eligible for permanent birth control.

The data were released at the 35th Annual Meeting of the American Association of Gynecologic Laparoscopists (AAGL).

The Essure procedure does not require incisions and can be done in a physician's office under local anesthesia. Tiny, lightweight Essure coils are passed through the cervix and...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Device Law Weekly

Source: Medical Device Law Weekly (2006-12-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry